First US sale for USCOM
Thursday, 28 July, 2005
Sydney-based devices company USCOM (ASX:UCM) has received its first US orders for its heart monitoring equipment. The USCOM Ultrasonic Cardiac Output Monitor, which the company says uses ultrasound technology to cost-effectively and non-invasively measure blood flow across the cardiac valves, was purchased by the Regional Healthcare System for Florida.
USCOM has also advanced the monitor's technology and the latest version of USCOM operating system software includes real-time calculation of beat-to-beat Systemic Vascular Resistance (SVR), a cardiovascular measure relating to cardiac output and blood pressure.
USCOM secured FDA approval to market the device in US in February and has had first sales in 11 other countries, including Australia.
Link between oestrogen and heart health found in women
Scientists found that oestrogen helps increase the ANXA1 protein, and when ANXA1 is missing, the...
Frequent nightmares accelerate aging, increase risk of death
Nghtmares independently predict faster biological aging and earlier mortality — even after...
Cardiac organoids bring hope for treating heart disease
Australian scientists have developed lab-grown, three-dimensional heart tissues known as cardiac...
